Positive Psychology Intervention for Hematopoietic Stem Cell Transplantation Survivors

Summary

This project aims to assess the efficacy of PATH, a tailored phone-delivered positive psychological intervention, for improving anxiety, depression, and quality of life in hematopoietic stem cell transplantation (HSCT) survivors.

What they want

The project involves conducting a randomized controlled trial (RCT) with 400 HSCT survivors to test the efficacy of the PATH intervention. PATH is an accessible, phone-delivered intervention with 15-20 minute sessions designed to cultivate gratitude, strengths, and meaning, delivered by interventionists from diverse backgrounds (nursing, social work, psychology). The research plan includes three aims: 1) test efficacy on anxiety, depression, and quality of life (QOL); 2) assess impact on positive well-being (gratitude, flourishing) and self-management targets (coping, physical activity); and 3) assess mediators and moderators of PATH's effect on anxiety symptoms and QOL.

Deliverables

Assessment of PATH efficacy on anxiety and depression symptoms and QOL in HSCT survivors
Assessment of PATH impact on positive well-being and self-management targets
Assessment of mediators and moderators of PATH's effect on anxiety symptoms and QOL

Technical requirements

Conduct a Randomized Controlled Trial (RCT) in 400 HSCT survivors
Deliver intervention via phone in 15-20 minute sessions

Key personnel

Interventionists (nursing, social work, or psychology backgrounds)
Dr. Amonoo and research team

Market context

inferred from NAICS

Professional, Scientific & Technical Services

NAICS 541720

US market size: $2.0T
Typical award: $25K – $50M

Typical buyers

All federal civilianDoDStates

Commonly required

8(a)WOSBSDVOSBPE/PMP

Sector-level estimate — full code lookup not yet in catalog.